Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
NCT04756544
demonstrated that after the intervention, both the probiotic and placebo groups showed significant improvements in their MADRS scores. However, these improvements were similar across both groups. The comparison between the probiotic and placebo groups resulted in an F value of 1.92 = 0.58 with a p-value of 0.45, indicating no significant difference. Furthermore, there was no notable difference in the change in MADRS scores, denoted as ∆MADRS, with U = 961, Z = 1.02, and a p-value of 0.31. Likewise, the percentage change in MADRS scores, represented as %∆MADRS, did not show a significant difference between the groups, with U = 1003.5, Z = 88, and a p-value of 0.38
Gawlik-Kotelnicka …